Nonmydriatic Fundus Cameras Market (2024 - 2030)

Market Size & Trends

The global nonmydriatic fundus cameras market size was valued at USD 173.5 million in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030. The increasing trend on retinal diseases such as diabetic retinopathy, AMD, and glaucoma has increased the need for nonmydriatic fundus cameras. With a rise in the occurrence of ailments such as diabetes and other chronic diseases, there is need for appropriate screening and monitoring procedures. These cameras are essential in cases of early identification, diagnosis and follow-up of these disorders, hence boosting sales.

Growth of healthcare facilities specifically in developing countries offer potentials to acquire new and improved diagnostic tools such as nonmydriatic fundus cameras. Increased consumer frequency in health care facilities leads to investment on new advanced technological equipment’s in ophthalmology. Moreover, modern technologies in the creation of diagnostic instruments have offered nonmydriatic fundus cameras that are of high resolution and are easy to use. These developments raise accuracy in image capturing and help in diagnoses, convincing healthcare practitioners and increasing incorporation towards the practice.

Patient and health care consumers’ awareness has improved on the need to regularly visit the ophthalmologist for testing and the early detection of the diseases. Community awareness programs and other strategies for the implementation of prevention enhance the usage of the nonmydriatic fundus cameras as essential in the screening processes. Since the population of the world and the advanced age group is constantly increasing, there is a higher possibility of certain eye diseases which mandatorily need to be checked and controlled at regular intervals.

Furthermore, some fundus cameras do not require pupils to be dilated during examination making their use friendly to the patients and can easily be done rapidly in virtually any setting including the offices of family physicians. Authorities’ efforts in the enhancement of eye care delivery also involve financing of better diagnostic equipment such as nonmydriatic fundus cameras. Market beneficiation can also be promoted by regulatory backing since it can guarantee that the gadgets are safe and meet the anticipated results.

Type Insights

The tabletop type segment dominated the nonmydriatic fundus cameras market with a revenue share of 51.0% in 2023. The tabletop nonmydriatic fundus cameras offer superior image resolution compared to portable ones, owing to their larger size and stable position, resulting in high-quality images with reduced vagueness. The user-friendly interface and automated functions enable technicians to capture quality images with minimal training, enhancing workflow efficiency in ophthalmic clinics and hospitals.

The handheld type segment is expected to register the fastest CAGR of 6.1% in the forecast period. Nonmydriatic handheld fundus cameras offer unparalleled portability and ease of transportation, making them ideal for ophthalmologists who need to conduct eye assessments in various settings. These devices eliminate the need for pharmacological pupil dilation, reducing patient discomfort and practitioner time consumption. This feature enhances the overall patient experience and examination efficiency, ultimately benefiting both patients and physicians.

End-use Insights

The hospitals segment dominated the nonmydriatic fundus cameras market with a revenue share of 44.8% in 2023. Most of the hospitals available today have a significant focus on eye care, with dedicated ophthalmology departments. This enables them to efficiently utilize nonmydriatic fundus cameras for diagnosis and treatment. Hospitals' ability to invest in infrastructure and cutting-edge technology makes them well-suited to spearhead various medical services, including intensive care, knowledge-based services, and technologically advanced diagnoses.

The ophthalmic & optometrist offices segment is projected to grow at the fastest CAGR of 6.5% over the forecast period. Ophthalmic and optometrist offices prioritize nonmydriatic fundus cameras due to their focus on eye care. The growing prevalence of lifestyle diseases, such as diabetes, and the aging population has created a significant demand for diagnostic devices in the eye care industry. Nonmydriatic fundus cameras are a valuable investment for many ophthalmic practices, offering a cost-effective solution for eye examinations with lower operating costs compared to traditional mydriatic systems.

Regional Insights

North America nonmydriatic fundus cameras market led the global nonmydriatic fundus cameras market with a revenue share of 37.4% in 2023. North America has a significant population affected by eye disorders such as diabetic retinopathy (DR) and age-related macular degeneration (AMD). The rising prevalence of these conditions necessitates advanced detection and diagnosis methods, including nonmydriatic fundus cameras. With a well-established healthcare system and a commitment to using cutting-edge technology, North America offers a prime market for specialized treatment and diagnostic solutions.

U.S. Nonmydriatic Fundus Cameras Market Trends

The nonmydriatic fundus cameras market in U.S. dominated the North America nonmydriatic fundus cameras market with a revenue share of 81.7% in 2023. Industry growth in the country is driven by an aging population and rising prevalence of chronic eye diseases such as diabetic retinopathy and age-related macular degeneration. Technological advancements, improved diagnostic capabilities, and portability have contributed to widespread adoption. Regulatory support and healthcare initiatives also promote the use of nonmydriatic handheld fundus cameras, solidifying the US market's leadership position.

Europe Nonmydriatic Fundus Cameras Market Trends

Europe nonmydriatic fundus cameras market is experiencing significant growth, driven by a well-established healthcare infrastructure, rising prevalence of eye disorders, and supportive government regulations. The aging population and increasing incidence of chronic diseases such as diabetes are fueling demand for early detection and screening tools. Continuous innovation by European manufacturers also contributes to market expansion.

Nonmydriatic fundus cameras market in Germany has a significant market in 2023. Germany has established itself as a hub for medical science innovation, driving advancements in nonmydriatic camera technology. As a result, German-made cameras have become increasingly competitive and popular, offering improved performance and capabilities. This focus on innovation has positioned Germany as a leader in the development of cutting-edge medical technology.

Asia Pacific Nonmydriatic Fundus Cameras Market Trends

Asia Pacific nonmydriatic fundus cameras market is anticipated to witness the fastest growth of 6.0% over the forecast period. The region's large and aging population has led to a significant incidence of eye diseases, including diabetic retinopathy and glaucoma. Nonmydriatic cameras are gaining popularity due to their speed and comfort, making them ideal for screening. Varying healthcare infrastructure and government initiatives promoting early detection of eye diseases are driving the demand for nonmydriatic cameras in the region.

Nonmydriatic fundus cameras market in China held a substantial market share in 2023. The investment in hospitals and clinics is escalating, accompanied by a growing demand for advanced diagnostic technology, including fundus cameras. This surge in demand is driving the adoption of these technologies among healthcare practitioners. Furthermore, Chinese suppliers are offering cost-effective solutions, making them a competitive option for healthcare facilities seeking to upgrade their diagnostic capabilities.

Key Nonmydriatic Fundus Cameras Company Insights

Some of the key companies in the nonmydriatic fundus cameras market Carl Zeiss Meditec AG; Kowa Company, Ltd.; Optomed Plc; Optovue, Incorporated; among others. The market is competitive, with several major players vying for dominance. Key players are leveraging strategic initiatives, including new product launches, partnerships, and geographic expansions, to enhance their market standing.

• Kowa Company Ltd, a Japanese conglomerate, operates in pharmaceuticals, healthcare equipment, and optics. Committed to enhancing global healthcare, Kowa invests in innovative solutions that prioritize patient-centric care.

• Optomed Plc specializes in medical technology, focusing on ophthalmic products and services. The company's expertise lies in nonmydriatic fundus cameras, essential tools for early diagnosis and management of various eye conditions. This technology enables healthcare professionals to provide accurate and timely patient care, thereby improving patient outcomes.

Recent Developments

• In July 2024, Topcon Healthcare, Inc. appointed Lance Patton as Chief Commercial Officer, leading the company's commercial transformation to a direct sales and service organization, focusing on customized solutions and AI-powered disease detection.

• In May 2024, Optomed launched the Optomed Aurora AEYE, a handheld fundus camera equipped with AI technology to provide immediate detection of mild diabetic retinopathy. The product has enabled on-the-spot screenings for patients with diabetes in primary care settings.

• In January 2024, NIDEK CO., LTD. and Orbis International collaborated to enhance artificial intelligence eye screenings in Vietnam, donating six specialized fundus cameras to support Orbis' AI-based diabetic retinopathy screening program.

• In December 2023, Carl Zeiss Meditec AG announced the acquisition the Dutch Ophthalmic Research Center in a strategic move, expanding its ophthalmic portfolio and digitally-enabled workflow solutions to address a wide range of eye conditions.

Nonmydriatic Fundus Cameras Market